Abstract 1600P
Background
Sarcopenia is a disorder that causes muscle mass and strength loss, which can result in diminished mobility and functional limits. Depression and a bad assessment of one's own health are common results among cancer patients. As a result, this study aimed to look at the association between sarcopenia, depression, and health perception.
Methods
Cancer patients were the subject of a retrospective study from January to April 2023. The study included 150 patients who had different forms of a verified cancer diagnosis. These individuals were admitted to Mayo Hospital's Palliative Care Cancer Department. The presence of depressive symptoms was assessed using the Patient Health Questionnaire (PHQ-9). SARC-F was used to measure all the five dimensions of sarcopenia. To examine self-perceived health, a self-report questionnaire was used. The relationships between sarcopenia, depression, and health perception were investigated using correlation analysis.
Results
We observed a significant and positive association between depression and the dimensions of sarcopenia. Specifically, we found a positive correlation between depression and SARC1=Strength (r = 0.378, p<0.01), SARC2=Assistance in walking (r = 0.390, p<0.01), SARC3=Rise from a chair (r = 0.488, p<0.01), and SARC4=Climb stairs (r = 0.392, p<0.01). However, we found a positive but insignificant relationship between depression and SARC5=Falls (r = 0.150, p>0.05). In addition, we discovered that patients' perception of poor health was correlated with depression (r = -0.391, p<0.01), SARC2=Assistance in walking (r = -0.235, p<0.01), SARC3=Rise from a chair (r = -0.259, p<0.01), and SARC4=Climb stairs (r = -0.277, p<0.01). However, we did not find a significant relationship between health perception and two dimensions of sarcopenia (i.e., SARC1=Strength and SARC5=Falls).
Conclusions
Sarcopenia adversely affects the physical and mental health of cancer patients. They feel depressed and perceive their health as bad which imparts a negative impact on the outcome of these patients.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1857P - Psychological distress in Georgian cancer patients undergoing chemotherapy: Before and after the COVID-19 pandemic
Presenter: Mariam Abuladze
Session: Poster session 05
1858P - Discrepancies between psychological stress and emotional care in cancer patients revealed in a social listening analysis
Presenter: Dalyong Kim
Session: Poster session 05
1859P - Digital goal management training as treatment for cognitive impairment in cervical cancer survivors: A feasibility study
Presenter: Elisabeth Areklett
Session: Poster session 05
1860P - Objective and subjective neurocognitive functioning (NCF) in advanced cancer survivors treated with immune checkpoint blockade (ICB)
Presenter: Nathalie Vanlaer
Session: Poster session 05
1861P - A randomized controlled trial on the efficacy and safety of the Untire app for moderate-to-severe cancer-related fatigue in German patients
Presenter: Simon Spahrkäs
Session: Poster session 05
1862P - Measuring the prevalence of fatigue in children with cancer: Evidence from Egypt
Presenter: Nourhan Abdalkader
Session: Poster session 05
1863P - Compassion fatigue among the staff involved in medical carcinology services
Presenter: Nouha Abidi
Session: Poster session 05
1864P - To what extent do nulliparous, female adolescents and young adults diagnosed with cancer have children after cancer treatment?
Presenter: Line Bentsen
Session: Poster session 05
1865P - Women with elderly early-stage breast cancer with type A personality may have decreased self-esteem after chemotherapy: A pilot study (POSEIDON Study)
Presenter: Ozgur Tanriverdi
Session: Poster session 05
1866P - Unmasking the extent of hidden sexual distress in young breast cancer survivors
Presenter: Zeineb Naimi
Session: Poster session 05